iSpecimen Inc. Made Headway
Thu, Sep 22, 2022 at 07:26 PM
iSpecimen Inc. (ISPC:NASDAQ) soared at $1.91, representing a gain of 26.5%. The stock got featured on our News Catalysts scanner on Wed, Aug 31, 2022 at 10:19 AM in the 'MISCELLANEOUS' category. From Thu, Sep 08, 2022, the stock recorded 20.00% Up Days and 27.27% Green Days
The stock spiked on Thu, Jul 07, 2022 at $3.26 with a volume of 2M+.
About iSpecimen Inc. (ISPC:NASDAQ)
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, tissues, and living cells for their research, with the available biospecimens.
Top 10 Gainers:
- Spero Therapeutics, Inc. (SPRO:NASDAQ), 167.74%
- Avenue Therapeutics, Inc. (ATXI:NASDAQ), 105.9%
- Panbela Therapeutics Inc. (PBLA:NASDAQ), 46.39%
- American Virtual Cloud Technologies, Inc. (AVCT:NASDAQ), 44.69%
- ShiftPixy, Inc. (PIXY:NASDAQ), 38.95%
- Cassava Sciences, Inc. (SAVA:NASDAQ), 35.65%
- Cano Health Inc. Class A (CANO:NYSE), 32.17%
- iSpecimen Inc. (ISPC:NASDAQ), 26.49%
- Heliogen Inc. (HLGN:NYSE), 23.56%
- Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ), 23.48%